PRKCD and Alzheimer disease: This study clearly showed the increased expression and activation of PKCδ in Aβ-stimulated peripheral T cells from early AD patients, whereas the same treatment induced two distinct (p)PKCδ and (p)PKCζ T cell subpopulations in severe AD patients (Miscia et al., 2009).